Low-density lipoprotein electronegativity is a novel cardiometabolic risk factor.
Low-density lipoprotein (LDL) plays a central role in cardiovascular disease (CVD) development. In LDL chromatographically resolved according to charge, the most electronegative subfraction-L5-is the only subfraction that induces atherogenic responses in cultured vascular cells. Furthermore, increas...
Main Authors: | Jing-Fang Hsu, Tzu-Chieh Chou, Jonathan Lu, Shu-Hua Chen, Fang-Yu Chen, Ching-Chu Chen, Jeffrey L Chen, MacArthur Elayda, Christie M Ballantyne, Steven Shayani, Chu-Huang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4159324?pdf=render |
Similar Items
-
Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis
by: Chih-Sheng Chu, et al.
Published: (2020-07-01) -
Electronegative very-low-density lipoprotein induces brain inflammation and cognitive dysfunction in mice
by: Ying-Shao Lin, et al.
Published: (2021-03-01) -
Electronegative low density lipoprotein induces renal apoptosis and fibrosis: STRA6 signaling involved[S]
by: Chao-Hung Chen, et al.
Published: (2016-08-01) -
The Potential Role of Electronegative High-Density Lipoprotein H5 Subfraction in RA-Related Atherosclerosis
by: Ching-Kun Chang, et al.
Published: (2021-10-01) -
Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases
by: Liang-Yin Ke, et al.
Published: (2020-11-01)